³Ô¹ÏÍøÕ¾

Latest pharmaceuticals News | Page 4

ADHD drug shortages: what to expect if you take Vyvanse and can’t access your usual dose
Intravenous iron treatment Ferinject® (ferric carboxymaltose) now approved for Australian children aged one to thirteen years living with iron deficiency anaemia
Do AI-driven Chemistry Labs Actually Work? New Metrics Promise Answers
Second Reading Speech, Competition and Consumer Amendment (Fair Go for Consumers And Small Business) Bill 2024
$14.4 million boost to provide relief for more Australians in need
Low-cost microbe can speed biological discovery
MinterEllison advises Arrotex on key health and beauty acquisitions
Opinion piece: Chocolate, cartels and competition
Australian retailers seek urgent resolution of DP World dispute
ADHD medication – can you take it long term? What are the risks and do benefits continue?
Works underway on Royal Hobart Hospital Pharmacy Redevelopment Project
Neuren Pharmaceuticals announces top-line results of Phase 2 NNZ-2591 trial
Eggs from men, sperm from women: how stem cell science may change how we reproduce
Neuren Pharmaceuticals completes enrolment in Pitt Hopkins syndrome Phase 2 trial
Fund disease prevention properly and rupture the pills and hospital beds pipeline: PHAA CEO
Developing a Superbase-Comparable BaTiO3−xNy Oxynitride Catalyst
COP28: Fighting AMR requires action on ground, Qu says
Dead & Co concert proceeds fund climate solutions
Clarity’s theranostic prostate cancer trial progresses at the highest dose level cohort
Researchers fix chirality of helical proteins
Island Pharmaceuticals doses first cohort in ISLA-101 Single Ascending Dose study
New Centre to support ‘optimal’ ageing
UQ leads state at Life Sciences Queensland Awards
Joint operation seizes $2 million worth of unlawfully imported therapeutic goods
Preserving antimicrobials for the well-being of humans, animals, plants and ecosystems
University of Sydney secures four prestigious ARC Linkage Grants
Did this chemical reaction create the building blocks of life on Earth?
Neuren Pharmaceuticals completes Phelan-McDermid syndrome Phase 2 trial 
Telix says first patient dosed in ProstACT study of prostate cancer candidate
New order for brewer’s yeast
Clarity says recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
Proposed Macquarie Park precinct to pave way for thousands of new homes
Scientists one step closer to re-writing world’s first synthetic yeast genome, unravelling the fundamental building blocks of life
Australia and UK sign Quantum statement
THE RESULTS ARE IN: Australia’s brightest healthcare students awarded national scholarship
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Bioprospecting the unknown: how bacterial enzymes encoded by unknown genes might help clean up pollution
Aboriginal leadership boost in WA’s wild sandalwood sector
Boost for WA’s health and life sciences on eve of AusBiotech 2023
Top performing ASX life science companies 26 October
Quantum computers in 2023: how they work, what they do, and where they’re heading
Shortage in regional nuclear medicine workforce attracts new financial support
Yeast speeds discovery of medicinal compounds in plants
Prime Minister’s Prizes for Science celebrate quantum computing
Arovella Therapeutics licences monoclonal antibody for cell therapy development
Significant development in mild cognitive impairment treatment revealed in Australia
Alexion data at 9th Joint ECTRIMS-ACTRIMS Meeting (MSMilan2023) showcase impact of C5 inhibition in NMOSD
Surgery switches to ‘low carbon’ – WA Health takes the knife to high-emissions anaesthetic